F-group (family)
3016.1.1.3 Aminotran_5
Ligands and drugs
785
Member domains
188
with ligand contacts (≤ 4 Å)
23.9% of members
152
with DrugDomain annotations
19.4% of members
100
with a DrugBank compound
12.7% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 3016.1.1.3 belongs to X-group 3016 C-terminal domain in some PLP-dependent transferases, which binds 8.0 ligand superclasses per 20 proteins, broader than 55% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00114 | PLP | Pyridoxal phosphate | 7 |
| DB04522 | SEP | Dexfosfoserine | 7 |
| DB00160 | ALA | Alanine | 6 |
| DB02824 | PLG | N-Pyridoxyl-Glycine-5-Monophosphate | 6 |
| DB04467 | PDA | N-(5'-phosphopyridoxyl)-L-alanine | 5 |
| DB00151 | CYS | Cysteine | 4 |
| DB03097 | 7TS | PMP-hydroxyisoxazole, pyridoxamine-5-phosphate-hydroxyisoxazole | 4 |
| DB04422 | HCS | Homocysteine | 4 |
| DB02079 | AOA | Aminooxyacetic acid | 2 |
| DB02142 | PMP | Pyridoxamine-5'-Phosphate | 2 |
| DB03345 | BME | Mercaptoethanol | 2 |
| DB09459 | TLA | L-tartaric acid | 2 |
| DB00974 | EDT | Edetic acid | 1 |
| DB02038 | DCS | D-[3-hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-N,O-cycloserylamide | 1 |
| DB02345 | SEC | Selenocysteine | 1 |
| DB03201 | DCY | D-Cysteine | 1 |
| DB03434 | MPO | 3-(N-morpholino)propanesulfonic acid | 1 |
| DB04217 | LPG | L-2-amino-3-butynoic acid | 1 |
| DB04332 | ETE | 2-{2-[2-2-(Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethanol | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CL | CHLORIDE ION | 16 |
| PLP | PYRIDOXAL-5'-PHOSPHATE | 13 |
| FE2metal | FE (II) ION | 12 |
| ZNmetal | ZINC ION | 12 |
| 8Q1 | S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate | 11 |
| SEP | PHOSPHOSERINE | 8 |
| EDT | {[-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-CARBOXYMETHYL-AMINO}-ACETIC ACID | 6 |
| PLG | N-GLYCINE-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YL-METHANE] | 6 |
| ALA | ALANINE | 5 |
| P15 | 2,5,8,11,14,17-HEXAOXANONADECAN-19-OL | 5 |
| PDA | 2-[(3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL)-AMINO]-PROPIONIC ACID | 5 |
| 7TS | (5-hydroxy-6-methyl-4-{[(3-oxo-2,3-dihydro-1,2-oxazol-4-yl)amino]methyl}pyridin-3-yl)methyl dihydrogen phosphate | 4 |
| C6P | N-({3-HYDROXY-2-METHYL-5-[(PHOSPHONOOXY)METHYL]PYRIDIN-4-YL}METHYL)-L-CYSTEINE | 4 |
| HCS | 2-AMINO-4-MERCAPTO-BUTYRIC ACID | 4 |
| BME | BETA-MERCAPTOETHANOL | 3 |
| CAmetal | CALCIUM ION | 3 |
| CYS | CYSTEINE | 3 |
| FES | FE2/S2 (INORGANIC) CLUSTER | 3 |
| 9YX | (2~{S},4~{S})-2-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]-1,3-thiazolidine-4-carboxylic acid | 2 |
| 9ZN | (2~{R})-3-methyl-2-[(~{E})-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methylideneamino]-3-sulfanyl-butanoic acid | 2 |